Simcere Pharmaceutical Group Limited (FRA:S2P)
1.250
+0.030 (2.46%)
At close: Jan 30, 2026
FRA:S2P Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 2,671 | 1,943 | 2,007 | 1,658 | 973.14 | 3,270 |
Short-Term Investments | 5.72 | - | 11.14 | 964.23 | 1,210 | - |
Trading Asset Securities | - | - | - | - | - | 3.63 |
Cash & Short-Term Investments | 2,676 | 1,943 | 2,018 | 2,623 | 2,183 | 3,274 |
Cash Growth | -12.44% | -3.73% | -23.04% | 20.12% | -33.31% | 263.04% |
Accounts Receivable | 2,638 | 2,704 | 2,645 | 2,339 | 2,399 | 1,871 |
Other Receivables | 76.4 | 60.06 | 50.73 | 39.89 | 37.37 | 43.79 |
Receivables | 2,715 | 2,764 | 2,695 | 2,379 | 2,436 | 1,915 |
Inventory | 658.73 | 683.97 | 770.14 | 371.59 | 290.96 | 311.13 |
Other Current Assets | 65.39 | 74.21 | 155.13 | 85.61 | 69.24 | 967.03 |
Total Current Assets | 6,115 | 5,466 | 5,639 | 5,458 | 4,980 | 6,467 |
Property, Plant & Equipment | 2,266 | 2,270 | 2,170 | 2,139 | 1,931 | 2,128 |
Long-Term Investments | 1,891 | 1,893 | 1,580 | 2,258 | 2,651 | 1,825 |
Goodwill | 142.47 | 142.47 | 142.47 | 172.79 | 172.79 | 172.79 |
Other Intangible Assets | 1,389 | 1,025 | 715.79 | 379.9 | 59.69 | 77.11 |
Long-Term Deferred Tax Assets | 519.59 | 435.59 | 317 | 326.71 | 289.97 | 210.09 |
Other Long-Term Assets | 181.73 | 178.19 | 188.95 | 53.79 | 76.56 | 63.53 |
Total Assets | 12,605 | 11,510 | 10,854 | 10,789 | 10,161 | 10,943 |
Accounts Payable | 187.91 | 275.73 | 317.22 | 335.43 | 323.95 | 242.08 |
Accrued Expenses | 846.84 | 1,031 | 1,045 | 1,124 | 1,032 | 1,155 |
Short-Term Debt | 1,050 | 1,050 | 762.43 | 1,184 | 991.57 | 1,561 |
Current Portion of Long-Term Debt | 0.71 | 0.72 | 252.71 | 108.37 | 538.51 | 232.2 |
Current Portion of Leases | 79.15 | 67.56 | 79.85 | 58.76 | 31.56 | 38.1 |
Current Income Taxes Payable | 88.96 | 154.36 | 17.9 | 10.56 | 16.16 | - |
Current Unearned Revenue | 383.22 | 28.16 | 43.31 | 63.34 | 26.14 | 18.76 |
Other Current Liabilities | 891.77 | 119.25 | 167 | 82.41 | 103.7 | 249.91 |
Total Current Liabilities | 3,529 | 2,727 | 2,686 | 2,967 | 3,064 | 3,497 |
Long-Term Debt | 7.89 | 8.25 | 205.85 | - | - | 1,276 |
Long-Term Leases | 91.69 | 82.42 | 128.4 | 155.92 | 74.24 | 193.43 |
Long-Term Unearned Revenue | 366.28 | 377.69 | 393.11 | 403.35 | 417.61 | 447.95 |
Long-Term Deferred Tax Liabilities | 67.58 | 72.7 | 102.68 | 115.29 | 142.77 | 193.6 |
Other Long-Term Liabilities | 1,309 | 1,174 | 115 | - | - | - |
Total Liabilities | 5,371 | 4,442 | 3,631 | 3,641 | 3,698 | 5,608 |
Common Stock | 3,184 | 3,174 | 3,174 | 3,081 | 3,003 | 3,003 |
Retained Earnings | 3,620 | 3,481 | 3,837 | 3,831 | 3,294 | 2,147 |
Comprehensive Income & Other | 430.28 | 413.29 | 211.61 | 219.72 | 139.96 | 151.48 |
Total Common Equity | 7,234 | 7,068 | 7,223 | 7,132 | 6,437 | 5,302 |
Minority Interest | - | - | - | 16.06 | 25.76 | 33.94 |
Shareholders' Equity | 7,234 | 7,068 | 7,223 | 7,148 | 6,463 | 5,336 |
Total Liabilities & Equity | 12,605 | 11,510 | 10,854 | 10,789 | 10,161 | 10,943 |
Total Debt | 1,230 | 1,209 | 1,429 | 1,507 | 1,636 | 3,300 |
Net Cash (Debt) | 1,447 | 733.7 | 589.08 | 1,116 | 547.34 | -26.14 |
Net Cash Growth | -22.82% | 24.55% | -47.21% | 103.86% | - | - |
Net Cash Per Share | 0.59 | 0.29 | 0.23 | 0.43 | 0.21 | -0.01 |
Filing Date Shares Outstanding | 2,475 | 2,486 | 2,617 | 2,660 | 2,628 | 2,609 |
Total Common Shares Outstanding | 2,475 | 2,486 | 2,617 | 2,660 | 2,628 | 2,609 |
Working Capital | 2,586 | 2,739 | 2,953 | 2,492 | 1,916 | 2,970 |
Book Value Per Share | 2.92 | 2.84 | 2.76 | 2.68 | 2.45 | 2.03 |
Tangible Book Value | 5,702 | 5,900 | 6,364 | 6,579 | 6,205 | 5,052 |
Tangible Book Value Per Share | 2.30 | 2.37 | 2.43 | 2.47 | 2.36 | 1.94 |
Machinery | - | 2,961 | 2,632 | 2,811 | 2,528 | 2,572 |
Construction In Progress | - | 343.38 | 343.47 | 202.13 | 95.75 | 66.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.